Jobs
View more job listings or post a job
Hangzhou Zenshine Pharmaceuticals Director/Senior Director, Oncology
Genentech Scientific Researcher / Senior Scientific Researcher, Drug Metabolism And Pharmacokinetics
Hughes and Associates Senior Scientist Large Molecule Bioanalysis
Hughes and Associates Associate Director DMPK
Hughes and Associates Associate Director, Clinical Pharmacology and Pharmacometrics
Hughes and Associates Senior Director Clinical Pharmacology
Genentech ASSOCIATE SCIENTIST/SCIENTIST – DRUG METABOLISM
Genentech Scientist–Drug Metabolism (Contract 2)
Genentech Scientist–Drug Metabolism (Contract 1)  
Drug Delivery Experts Associate Scientist
Post a job

Workshop

Clinical Pharmacology & Modeling Strategies for your Drug Development Program: Fundamentals, Best Practices and Real World Applications


Speakers: David Lau (Foresee Pharmaceuticals), Geoff Banks (Nuventra), Mark Sale (Nuventra), Lauren Lohmer (Nuventra)
Organizers: Kelly Gelinne (Nuventra), David Lau (Foresee Pharmaceuticals)
Date: 12/11/2017
Time: 8:45-17:00
Registration fee (USD): Academic: $125; Regular: $195; For unemployed or students: $30; For major-sponsor rep (incl lunch): $0; For vendor-show rep: $35;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor:
Vendor show vendors registered to date: (4)Applied BioMath; ICON PLC; Spaulding Clinical Research; WORLDWIDE CLINICAL TRIALS
Registration: http://www.PBSS.org
Registration deadline:12/8/2017  (it will close sooner if the seating cap is reached)

About the Topic

Preliminary Agenda

8:45 – 9:00 Welcome and Intro

9:00 – 10:30 – David Lau (Senior Vice President, NCE Preclinical and Clinical Development, Foresee Pharmaceuticals)

Purpose of Clin Pharm Studies in Drug Development

Type of Clin Pharm studies (SAD, MAD, BA/BE, DDI, Disease population, QT, etc)

  • What are these studies
  • When to do the studies
  • Typical study design
  • Examples

10:30 – 11:00 – Break and Vendor Presentation

11:00 – 12:30 – Geoff Banks (CEO, Nuventra)

How to Form a Clin Pharm Strategy for your NDA / BLA

  • What studies you do & don’t need
  • “Gap analysis” in your program
  • Real world examples

12:30 – 1:30 – Lunch

1:30 – 3:00 – Mark Sale (Senior Vice President, Pharmacometrics, Nuventra)  

Modeling & Simulation / Population PK Fundamentals

  • What is it?
  • How do you do it?
  • Allometric scaling
  • How do you use it for safety and efficacy?

3:00 – 3:30 Break and vendor presentation

3:30 – 5:00  – Mark Sale and Lauren Lohmer (Manager, Clinical Pharmacology, Nuventra)

Using Modeling & Simulation to Avoid Clinical Trials

  • Overview and case studies:
    • CQT
    • Exposure response
    • Additional DDI studies
    • Special population studies
    • Renal impairment


2019-01-18, Fluorescence Imaging for the da Vinci Robotic Surgery Platform
2019-02-07, Covalent Inhibitor Drug Discovery & Development: Biology, Chemistry, PK, Safety and Case Studies (Jointly with Bay Area PKPD Network)
2019-03-07, Promising therapeutic approaches and transnational medicine from SPARK: an academic-industry collaboration to advance novel therapeutics (A Joint Symposium by PBSS and Stanford SPARK Program)
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 12/18/2018; Visited: 472; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)